[1]邵 娟,白淑玮,田蕴霖.高迁移率族蛋白B-1和NADPH氧化酶衍生活性氧对糖尿病视网膜病变大鼠视网膜电图波幅和玻璃体通透性的影响[J].陕西医学杂志,2022,51(5):515-519,524.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.001]
 SHAO Juan,BAI Shuwei,TIAN Yunlin.Effects and mechanism of high mobility group box-1 and nicotinamide adenine dinucleotide phosphate oxidase on electroretinogram amplitude and vitreous permeability of diabetic retinopathy rats[J].,2022,51(5):515-519,524.[doi:DOI:10.3969/j.issn.1000-7377.2022.05.001]
点击复制

高迁移率族蛋白B-1和NADPH氧化酶衍生活性氧对糖尿病视网膜病变大鼠视网膜电图波幅和玻璃体通透性的影响
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年5期
页码:
515-519,524
栏目:
基础研究
出版日期:
2022-05-05

文章信息/Info

Title:
Effects and mechanism of high mobility group box-1 and nicotinamide adenine dinucleotide phosphate oxidase on electroretinogram amplitude and vitreous permeability of diabetic retinopathy rats
作者:
邵 娟白淑玮田蕴霖
(西安市人民医院 西安市第四医院,陕西 西安710004)
Author(s):
SHAO JuanBAI ShuweiTIAN Yunlin
(Xi'an People's Hospital,Xi'an 710004,China)
关键词:
高迁移率族蛋白1 还原型烟酰胺腺嘌呤二核苷酸磷酸 非吞噬细胞氧化酶-2 玻璃体通透性 视网膜电图波幅 玻璃体
Keywords:
High mobility group box-1 protein Nicotinamide adenine dinucleotide phosphate Non-phagocytic cell oxidase 2 Vitreous permeability Electroretinogram amplitude Vitreous body
分类号:
R 774.1
DOI:
DOI:10.3969/j.issn.1000-7377.2022.05.001
文献标志码:
A
摘要:
目的:探究高迁移率族蛋白B-1(HMGB1)和还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶衍生活性氧(ROS)对糖尿病视网膜病变(DR)大鼠视网膜电图波幅和玻璃体通透性的影响及机制。方法:选取40只雄性SD大鼠,根据实验目的将大鼠分为对照组、DR模型组、HMGB1注射组和ROS抑制剂组。使用链脲佐菌素诱导大鼠糖尿病,进而发展DR模型。通过2'-7'-二氯荧光素-二乙酸酯(DCFH-DA)检测大鼠视网膜组织匀浆中ROS的生成。通过蛋白印迹分析视网膜组织中Nox2、HMGB1、Occludin和ZO-1的蛋白表达。通过PCR分析大鼠视网膜组织匀浆中PARP-1和Caspase 3的mRNA表达。通过视网膜电图分析大鼠a波和b波振幅。通过测量FITC-BSA荧光评估大鼠玻璃体通透性。结果:DR模型组和HMGB1注射组较对照组大鼠视网膜ROS水平升高(均P<0.05),ROS抑制剂组较DR模型组和HMGB1注射组ROS水平降低(均P<0.05)。DR模型组和HMGB1注射组较对照组Nox2和HMGB1的蛋白表达升高(均P<0.05),ROS抑制剂组较HMGB1注射组和DR模型组Nox2和HMGB1的蛋白表达降低(均P<0.05)。HMGB1注射组和DR模型组较对照组大鼠视网膜PARP-1和Caspase 3的mRNA表达升高(均P<0.05)。HMGB1注射组和DR模型组较对照组a波和b波振幅减少(均P<0.05),ROS抑制剂组较HMGB1注射组和DR模型组振幅升高(均P<0.05)。HMGB1注射组和DR模型组较对照组Occludin和ZO-1的蛋白表达降低(均P<0.05),ROS抑制剂组较HMGB1注射组和DR模型组Occludin和ZO-1的蛋白表达升高(均P<0.05)。DR模型组和HMGB1注射组较对照组荧光强度升高(P<0.05),ROS抑制剂组较DR模型组和HMGB1注射组荧光强度降低(P<0.05)。结论:糖尿病视网膜组织中HMGB1和Nox衍生的ROS之间存在正反馈,这可能是促进糖尿病诱导的视网膜电图波幅降低和玻璃体通透性增加的机制。
Abstract:
Objective:To explore the effects and mechanism of high mobility group box-1(HMGB1)and nicotinamide adenine dinucleotide phosphate(NADPH)oxidase on the amplitude of electroretinogram and the permeability of vitreous of diabetic retinopathy(DR)rats.Methods: Forty male SD rats were divided into control group,DR model group,HMGB1 injection group and ROS inhibitor group.Streptozotocin was used to induce diabetes in rats,and DR model was developed.ROS in rat retinal homogenate was detected by DCFH-DA.The protein expressions of Nox2,HMGB1,Occludin and ZO-1 in retinal tissue were analyzed by Western blot.The mRNA expressions of PARP-1 and Caspase-3 in rat retinal homogenate were analyzed by PCR.The amplitude of a wave and b wave in rats was ananlyzed by electroretinogram.Rat vitreous permeability was evaluated by measuring FITC-BSA fluorescence.Results:The level of ROS in the retina of DR model group and HMGB1 injection group was higher than that of the control group,and the level of ROS in ROS inhibitor group was lower than that of DR model group and HMGB1 injection group(all P<0.05).The expression levels of Nox2 and HMGB1 proteins in DR model group and HMGB1 injection group were higher than those in control group,and the expression levels of Nox2 and HMGB1 proteins in ROS inhibitor group were lower than those in HMGB1 injection group and DR model group(all P<0.05).The expression levels of PARP-1 and Caspase-3 mRNAs in retina of rats in HMGB1 injection group and DR model group were higher than those in control group(all P<0.05).Compared with the control group,the amplitude of a wave and b wave in HMGB1 injection group and DR model group decreased,and the amplitude of ROS inhibitor group increased(all P<0.05).The expression levels of Occludin and ZO-1 proteins in HMGB1 injection group and DR model group were lower than those in control group,and the expression levels of Occludin and ZO-1 proteins in ROS inhibitor group were higher than those in HMGB1 injection group and DR model group(all P<0.05).The fluorescence intensity of DR model group and HMGB1 injection group was higher than that of the control group,and the fluorescence intensity of ROS inhibitor group was lower than that of DR model group and HMGB1 injection group(all P<0.05).Conclusion:There is a positive feedback between HMGB1 and Nox-derived ROS in the diabetic retina,which may be the mechanism that promotes the decrease in the amplitude of the diabetic-induced electroretinogram and the increase in the permeability of the vitreous.

参考文献/References:

[1] 杜军辉,张 中,柴新红,等.复方血栓通联合全视网膜光凝对糖尿病视网膜病变患者血清hs-CRP、IL-8的影响[J].陕西中医,2017,38(6):708-709.
[2] Kjellstrom U,Martell S,Brobeck C,et al.Autosomal recessive stickler syndrome associated with homozygous mutations in the COL9A2 gene[J].Ophthalmic Genet,2021,42(6):1-9.
[3] Jiang D,Xiong G,Feng H,et al.Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex defect-induced degeneration[J].Theranostics,2019,9(8):2395-2410.
[4] Napolitano F,Iorio V,Iorio G,et al.Early posterior vitreous detachment is associated with LAMA5 dominant mutation[J].Ophthalmic Genet,2019,40(4):1-4.
[5] 马为梅,李春花,雷晓琴,等.雷珠单抗玻璃体腔按需注射治疗视网膜分支静脉阻塞继发黄斑水肿疗效研究[J].陕西医学杂志,2019,48(11):1552-1555.
[6] 李春花,吴冠吉,惠 娜,等.糖尿病视网膜病变激光治疗后干眼治疗临床研究[J].陕西医学杂志,2018,47(2):156-158.
[7] 罗文强,茹 平.血清Gas6和TSP-1水平与糖尿病视网膜病变的相关性研究[J].现代检验医学杂志,2020,35(1):71-74.
[8] 谢瑞敏,李 想,李强强,等.HMGB1对大鼠糖尿病足溃疡炎症的影响及机制分析[J].现代生物医学进展,2020,20(13):2429-2434.
[9] 卢淑文,蔡 洁,唐东永,等.玻璃体内注射联合全身应用更昔洛韦治疗AIDS合并巨细胞病毒视网膜炎的临床疗效[J].眼科新进展,2019,39(9):840-844.
[10] 狄 宇,郭立斌,叶俊杰,等.兔眼玻璃体腔注射更昔洛韦的视网膜毒性研究[J].中华眼科杂志,2020,56(4):279-285.
[11] 丁庭庭,钟 兴,杜益君,等.2型糖尿病患者葡萄糖范围内时间和平均血糖波动幅度与糖尿病视网膜病变相关性的研究[J].中国糖尿病杂志,2021,29(6):443-447.
[12] 曲 萌,于春艳,翁诗雅,等.北五味子提取物对糖尿病大鼠心肌组织中Nox2和p47phox表达的影响[J].吉林大学学报:医学版,2020,46(5):1029-1035.
[13] 刘 培,彭 俊,李书楠,等.益气养阴活血利水法联合康柏西普对非增殖期糖尿病视网膜病变患者视网膜电图的影响[J].陕西中医,2020,41(6):728-732.
[14] Naderi A,Zahed R,Aghajanpour L,et al.Long term features of diabetic retinopathy in streptozotocin-induced diabetic Wistar rats[J].Exp Eye Res,2019,184:213-220.
[15] You C,Lasave AF,Kubaisi B,et al.Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for birdshot retinochoroidopathy[J].Ocul Immunol Inflamm,2020,28(6):1-9.
[16] 叶阳君,曾广川,廖 武,等.康柏西普眼内注射治疗增殖期糖尿病视网膜病变疗效及对患者视网膜神经纤维层厚度的影响[J].陕西医学杂志,2019,48(5):654-656,660.
[17] 汪雨静,宫丽鸿,杨柏松,等.稳斑汤含药血清对巨噬细胞泡沫化自噬及凋亡相关蛋白Beclin1、Bcl2和Caspase 3表达的影响[J].沈阳药科大学学报,2020,37(4):44-49.
[18] 薛冬冬,张 翔,曹仁俊,等.聚腺苷二磷酸核糖聚合酶1与糖尿病心肌病[J].中国糖尿病杂志,2020,28(3):75-78.
[19] 陈 丰,陈志清,钟桂玲,等.葛根素预处理对心肌梗死模型大鼠HMGB1的表达及心肌细胞凋亡的影响[J].广西医科大学学报,2020,37(8):1404-1409.
[20] 王晓会,肖 琛,赵和平,等.低水平铅暴露损伤小鼠糖耐量及视网膜血管渗透性促进糖尿病视网膜病变发生[J].癌变?畸变?突变,2020,32(2):139-144.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81302198)
更新日期/Last Update: 2022-05-05